PET/MRI: pictorial review of hepatobiliary and pancreatic applications
Mohamed Awali,Maria El Homsi,Tyler J. Fraum,Anup S. Shetty,Maria R. Ponisio,Karem Gharzeddine,Joyce Mhlanga,Nadine Mallak,Spencer Behr,Malak Itani
DOI: https://doi.org/10.1007/s00261-024-04548-6
IF: 2.4
2024-09-11
Abdominal Radiology
Abstract:PET and MRI both play valuable roles in the management of hepatobiliary and pancreatic (HBP) malignancies. Simultaneous PET/MRI combines the excellent soft-tissue resolution and anatomic details from MRI with functional information from PET in a single comprehensive examination. MRI is the main imaging modality in evaluating HCC, playing important roles in screening, characterization, local extent, and evaluating tumor response, whereas 18 F-fluorodeoxyglucose (FDG) PET can help evaluate for lymph node involvement and metastatic disease. In cholangiocarcinoma and pancreatic malignancies, both PET and MRI have excellent utility in initial staging as well as assessing treatment response. In all HBP malignancies, FDG-PET/MRI is a unique problem-solving tool in complex cases and diagnostic challenges, especially after locoregional therapy and when differentiating residual or recurrent viable disease from inflammatory and other benign processes. In this manuscript, we review the role of PET/MRI in the diagnosis, staging, assessing treatment response, and characterizing post-treatment processes. With the introduction of multiple new tracers, the value of PET/MRI has not yet been fully realized, and more studies are needed to demonstrate the utility and efficacy of PET/MRI in improving patient care in hepatobiliary and pancreatic oncology.
radiology, nuclear medicine & medical imaging